AstraZeneca Coronavirus Vaccine In Trouble Again As Wrong Dosage In Human Trials Produced A False Result Regarding Efficacy Confirming Previous Site Claims

AstraZeneca Coronavirus Vaccine In Trouble Again As Wrong Dosage In Human Trials Produced A False Result Regarding Efficacy Confirming Previous Site Claims

November 28. 2020

AstraZeneca

The AstraZeneca vaccine is in trouble again. A report was released this week revealing participants in the human trial of the drug were only given a half a dose, which produced a false result of 90% efficacy. The error was recently caught and it was revealed the vaccine's efficacy is actually 62 %, which is low and ineffective.

As such, AstraZeneca has restarted their trial due to the very serious error. This development further supports my previous, time stamped, exclusive articles I authored about the coronavirus vaccines as a warning:

Johnson & Johnson Are The Second Pharma Giant To Pause Coronavirus Vaccine Trials Due To A Participant Developing Unexplained Illnesses Confirming Previous Site Claims

Coronavirus Vaccine Makes Patient Seriously Ill With Transverse Myelitis Confirming Previous Site Claims About Safety Issues

Coronavirus Vaccines In Trouble As Participant In Research Trial Becomes Seriously Ill Confirming Previous Site Claims

Coronavirus Vaccine Trial Makes More Participants Sick With Mystery Illnesses Confirming Previous Site Claims

AstraZeneca Coronavirus Vaccine Trial Participant Dies Confirming Previous Claims

I do not write these warnings to be mean or vicious. And as stated previously on the site I am not an anti-vaxxer (against vaccines). However, the coronavirus (Covid-19) is a novel ("new") virus whose behaviors many scientists do not fully understand.

Therefore, rushing a vaccine regarding a deadly virus is not a good idea. There is a public health risk present and it needs to be addressed, lest the vaccines end up being bad and do more harm than good in the short or longrun.

What I have stated in time stamped articles on this site and social networking have proven true and correct. See "Related Articles" segment below for 25 original articles I wrote about coronavirus that months later proved true and correct.

STORY SOURCE

The AstraZeneca Covid Vaccine Data Isn't Up to Snuff

11.25.2020 08:00 AM - There's been even more good news this week, this time from the Oxford-AstraZeneca trials. But a closer look reveals some very shaky science. The makers of a third coronavirus vaccine announced positive results in clinical trials on Monday, setting off yet another round of excited news reports.

This one, produced by a partnership between a University of Oxford research institute, its spinout company Vaccitech, and the pharmaceutical company AstraZeneca, does not need to be stored at freezing temperatures and would be cheaper and easier to produce than the high-efficacy vaccines produced by BioNTech-Pfizer and Moderna. Indeed, according to an initial write-up in The New York Times, Oxford-AstraZeneca’s is “expected to be relied upon heavily across the globe, to help curb a pandemic that has killed more than 1.3 million people.”

Sounds like great news, right? Monday’s press release from AstraZeneca presents “convincing evidence that [the vaccine] works,” said Science. But not everyone has been convinced. The price of AstraZeneca’s shares actually dropped on the news, and an analysis from an investment bank concluded, “We believe that this product will never be licensed in the US.” Over at STAT News, Anthony Fauci cautioned that we’ll need to see more data before coming to a conclusion. The skeptics have strong reasons to be concerned: This week’s “promising” results are nothing like the others that we’ve been hearing about in November—and the claims that have been drawn from them are based on very shaky science...

There are other problems, too. In the press release, Oxford-AstraZeneca reports that two of the dosing regimens “demonstrated efficacy.” Presumably, none of the others did, but they didn’t give specifics. Of the only two regimens they reported, one (the mistaken first half-dose, followed by a full dose at least a month later) came in at 90 percent, and the other (two standard doses at least a month apart) achieved only 62 percent efficacy...

https://www.wired.com

AstraZeneca manufacturing error clouds vaccine study results

November 25, 2020 - LONDON (AP) — AstraZeneca and Oxford University on Wednesday acknowledged a manufacturing error that is raising questions about preliminary results of their experimental COVID-19 vaccine.

A statement describing the error came days after the company and the university described the shots as “highly effective” and made no mention of why some study participants didn’t receive as much vaccine in the first of two shots as expected.

In a surprise, the group of volunteers that got a lower dose seemed to be much better protected than the volunteers who got two full doses. In the low-dose group, AstraZeneca said, the vaccine appeared to be 90% effective. In the group that got two full doses, the vaccine appeared to be 62% effective. Combined, the drugmakers said the vaccine appeared to be 70% effective. But the way in which the results were arrived at and reported by the companies has led to pointed questions from experts...

https://apnews.com

AstraZeneca Faces Mounting Vaccine Questions After Dosing Error

November 26th, 2020, 11:18 AM EST - AstraZeneca Plc and the University of Oxford, among the front-runners in the quest to deliver a Covid-19 vaccine, face mounting questions about their trial results after acknowledging a manufacturing error. Sam Fazeli of Bloomberg Intelligence has the details on "Bloomberg Markets."

https://www.bloomberg.com

RELATED ARTICLES

China And New York Hospitals Using Vitamin C To Aid In Treating Coronavirus Patients (Confirming Previous Claims)

Reports Confirm Obesity And Compromised Immune System Linked To Severity Of Coronavirus Infections As Previously Stated On The Site

Scientists Confirm 8 Coronavirus Strains Are Circling The Globe As Previously Stated On The Site (Covid-19)

New Scientific Study Confirms Coronavirus Sufferers Having Difficulty Expelling CO2 As Previously Stated On The Site

Coronavirus Infection Rate Skyrockets Among American Kids With The Reopening Of Schools As Previously Predicted On The Site

Britain Death Toll From Coronavirus Becomes The Highest In Europe Due To Prime Minister Boris Johnson's Failed Herd Immunity Strategy

Theresa May And Boris Johnson Under-Funding Of The NHS Left The Health Service Ill-Prepared To Counter The Effects Of The Coronavirus (Covid-19)

Man In Hong Kong Contracts Coronavirus For A Second Time Confirming Previous Site Claims (Video)

The Coronavirus Pandemic Has Sent The U.S. Economy To Historically High Unemployment Levels (Video)

Coronavirus Vaccine Makes Patient Seriously Ill With Transverse Myelitis Confirming Previous Site Claims About Safety Issues